Join
Live feed
·
INSIDERFilingvia Quantisnow
AbCellera Biologics Inc. logo

Chief Financial Officer Booth Andrew bought $145,692 worth of shares (42,600 units at $3.42), increasing direct ownership by 28% to 195,600 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
ABCL· AbCellera Biologics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ABCL (AbCellera Biologics Inc.) and more on Quantisnow.